<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/278115-a-method-for-making-a-slow-release-estradiol-formulation by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:35:09 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 278115:&quot;A METHOD FOR MAKING A SLOW RELEASE ESTRADIOL FORMULATION&quot;</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">&quot;A METHOD FOR MAKING A SLOW RELEASE ESTRADIOL FORMULATION&quot;</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention provides slow release estradiol-progesterone formulations that can be used in either contraception or hormone replacement therapies. The formulations comprise shaped particles of estradiol that is in a hemicrystalline form that exhibits especially low dissolution rates. The shaped particles comprise estradiol compounded in a 1:1 molar ratio with cholesterol, and are administered in combination with progesterone. The slow release formulations of the present invention afford the dual advantages of a low dose estradiol formulation with a low frequency administration regimen. The formulations can be parenterally administered once a month or less often.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>A method for making a slow release estradiol formulation comprising:<br>
(a)	creating particles consisting essentially of estradiol and<br>
cholesterol in mole ratio of 3:1 to 1:3 and wherein either or both are in an<br>
amorphous or polymorphous form;<br>
(b)	exposing said particles to an atmosphere saturated with<br>
acetone and water;<br>
(c)	repeating step (b);<br>
(d)	exposing said particles to an atmosphere saturated with<br>
ethanol and water;<br>
(e)	drying the particles; and<br>
(f)	recovering said particles;<br>
wherein the Estradiol Dissolution Rate of the recovered particles is less than 20 %.<br>
<br>
<br>
<br>
<br>
<br>
I CLAIM:<br>
1.	A method for making a slow release estradiol formulation comprising:<br>
(a)	creating particles consisting essentially of estradiol and<br>
cholesterol in mole ratio of 3:1 to 1:3 and wherein either or both are in an<br>
amorphous or polymorphous form;<br>
(b)	exposing said particles to an atmosphere saturated with<br>
acetone and water;<br>
(c)	repeating step (b);<br>
(d)	exposing said particles to an atmosphere saturated with<br>
ethanol and water;<br>
(e)	drying the particles; and<br>
(f)	recovering said particles;<br>
wherein the Estradiol Dissolution Rate of the recovered particles is less than 20 %.<br>
2.	The method as claimed in claim 1, wherein the acetone and water<br>
mixture is 65 mole % to 80 mole % acetone and 20 mole % to 35 mole %<br>
water.<br>
3.	The method as claimed in claim 1, wherein the ethanol and water<br>
mixture is 95 - 99 mole % ethanol and 5-1 mole % water.<br>
4.	The method as claimed in claim 1, wherein step (b) is performed over<br>
at least 24 hours, and step (c) is performed twice.<br>
5.	A method for making a slow release estradiol formulation comprising:<br>
<br>
(a)	creating particles consisting essentially of estradiol and<br>
cholesterol in mole ratio of 1:1  and wherein either or both are in an<br>
amorphous or polymorphous form;<br>
(b)	exposing said particles to an atmosphere saturated with<br>
acetone and water for three consecutive stages;<br>
(c)	exposing said particles to an atmosphere saturated with<br>
ethanol and water;<br>
(d)	drying the particles at 40 - 50°C for at least 24 hours; and<br>
(e)	recovering said particles;<br>
wherein the Estradiol Dissolution Rate of the recovered particles is 18% or less.<br>
6.	The method as claimed in claim 5, wherein the acetone and water<br>
mixture is 70 - 75 mole % acetone and 25 - 30 mole % water.<br>
7.	The method as claimed in claim 5, wherein the ethanol and water<br>
mixture is 95 - 99 mole % ethanol and 5-1 mole % water.<br>
8.	A pharmaceutical formulation in unit dose form comprising:<br>
(a)	5 mg to 15 mg 17-p-estradiol admixed with cholesterol in<br>
a molar ratio of 3:1 to 1:3; and<br>
(b)	200 mg to 500 mg progesterone,<br>
wherein the weight ratio of 17-p-estradiol to progesterone is between 1:13 to 1:100; and wherein the 17-p-estradiol consists of a hemicrystalline form that is 50-60% amorphous and 40-50% crystalline; and the Estradiol Dissolution Rate of the formulation is 20% or less.<br>
9.	The pharmaceutical formulation as claimed in claim 8, wherein the<br>
17-p-estradiol consists of a hemicrystalline form that is 55% amorphous<br>
and 45% crystalline.<br>
10.	The pharmaceutical formulation as claimed in claim 8, wherein the<br>
Estradiol Dissolution Rate is 6% or less.<br>
11.	The pharmaceutical formulation as claimed in claim 8, wherein the<br>
estradiol/ cholesterol admixture and the progesterone are formulated as<br>
microspheres of 35 to 75 nm diameter.<br>
<br>
12.	Microspheres of estradiol and cholesterol in 1:1 molar ratio having an<br>
Estradiol Dissolution Rate of 6% or less.<br>
13.	The   microspheres   as   claimed   in   claim   12.,   having   an   X-ray<br>
crystallographic spectra substantially the same as Figure 22.<br>
14.	The  microspheres  as  claimed  in  claim   12,  wherein  the  estradiol<br>
consists of a hemicrystalline form where 50-60% is amorphous and 40-50%<br>
is crystalline.<br>
15.	The microspheres as claimed in claim 12, wherein the estradiol is in a<br>
hemicrystalline form that is 55% amorphous and 45% crystalline.<br>
16.	The microspheres as claimed in claim 12, wherein the estradiol is 17-<br>
p-estradiol.<br>
17.	A pharmaceutical formulation comprising a contraceptive-effective and<br>
hormone-replacement-effective amount of 17-ß-estradiol and progesterone<br>
in a weight ratio .of from 1:13 to 1:100; and wherein the 17-ß-estradiol is<br>
compounded in discrete particles in admixture with cholesterol.<br>
18.	The formulation as claimed in claim 17, wherein the weight ratio of<br>
17-p-estradiol:progesterone is 9:400.<br>
19.	The formulation as claimed in claim 17, wherein the 17-ß-estradiol<br>
and cholesterol are compounded in a 1:1 molar ratio into microspheres, and<br>
the progesterone is separately compounded into discrete microspheres.<br>
20.	The formulation as claimed in claim 19, wherein the microspheres<br>
have a diameter of between 25 µm and 105 µm.<br>
21.	The method as claimed in claim 1, wherein the molar ratio of estradiol<br>
to cholesterol is from 1:2 to 2:1.<br>
22.	The method as claimed in claim 1, wherein the molar ratio of estradiol<br>
to cholesterol is 1:1.<br>
23.	The method as claimed in claim 1, further comprising exposing said<br>
particles to an atmosphere saturated with ethanol and water.<br>
24.	The method as claimed in claim 1, wherein the step of exposing the<br>
particles to an atmosphere saturated with acetone and water occurs over 72<br>
hours at 60°C.<br>
25.	The method as claimed in claim 1, wherein the mole ratio of estradiol<br>
to cholesterol is 1:1.<br>
26.	The formulation as claimed in claim 8, wherein the mole ratio of 17-ß<br>
estradiol to cholesterol is 1:1.<br>
27.	The formulation as claimed in claim 8, wherein the weight ratio of 17-<br>
ß-estradiol to progesterone is 9:400.<br>
28.	The formulation as claimed in claim 8, comprising 9 mg of 17-ß-<br>
estradiol and 400 mg of progesterone.<br>
29.	The formulation as claimed in claim 8, wherein the 17-ß-estradiol and<br>
cholesterol are in admixture in discrete particles, and the progesterone is in<br>
separate and discrete particles.<br>
30.	The     formulation     as     claimed     in     claim     8,     wherein     the<br>
estradiol/cholesterol particles and the progesterone particles are all in the<br>
form of microspheres having diameter of 25 µm to 125 µm.<br>
31.	The formulation as claimed in claim 30, wherein the microspheres<br>
have a diameter of 35 µm to 75 µm.<br>
32.	A    method    for    making   a    slow    release    estradiol    formulation<br>
substantially as herein described with reference to foregoing description.<br>
33.	A pharmaceutical formulation in  unit dose form  substantially as<br>
herein described with reference to foregoing description.<br>
</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/viewdoc.aspx?id=BsmHnsueX9ZCcVnEkPQ4nA==&amp;amp;loc=+mN2fYxnTC4l0fUd8W4CAA==" target="_blank" style="word-wrap:break-word;">http://ipindiaonline.gov.in/patentsearch/GrantedSearch/viewdoc.aspx?id=BsmHnsueX9ZCcVnEkPQ4nA==&amp;amp;loc=+mN2fYxnTC4l0fUd8W4CAA==</a></p>
		<br>
		<div class="pull-left">
			<a href="278114-green-process-for-preparation-of-halophenylacetic-acids-and-corresponding-esters.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="278116-solder-alloy.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>278115</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2777/DELNP/2009</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>52/2016</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>16-Dec-2016</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>14-Dec-2016</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>27-Apr-2009</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>SKENDI FINANCE LTD.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>AKARA BUILDING, 24 DE CASTRO STREET, WICKHAMS CAY I ROAD TOWN, TORTOLA BRITISH VIRGIN ISLANDS</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>JOHN CLAUDE SAVOIR</td>
											<td>AV. PROGRESO #44, COYOACAN, MEXICO 04100, MEXICO.</td>
										</tr>
										<tr>
											<td>2</td>
											<td>JUAN ANGELES URIBE</td>
											<td>VALLE DE CUERNO 81, VALLE DE ARAGON, NEZAHUALCOYOTL, MEXICO 57000, MEXICO.</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 9/14</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/IB2004/001930</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2004-06-10</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/477,939</td>
									<td>2003-06-13</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/278115-a-method-for-making-a-slow-release-estradiol-formulation by HTTrack Website Copier/3.x [XR&CO'2014], Thu, 04 Apr 2024 23:35:10 GMT -->
</html>
